share_log

CEO Zhi Zhuang, BMC Medical Co., Ltd.'s (SZSE:301367) Largest Shareholder Sees Value of Holdings Go Down 7.6% After Recent Drop

CEO Zhi Zhuang, BMC Medical Co., Ltd.'s (SZSE:301367) Largest Shareholder Sees Value of Holdings Go Down 7.6% After Recent Drop

BMC醫療有限公司的最大股東朱壯總裁最近股票跌了7.6%,其持股價值隨之下降。
Simply Wall St ·  07/03 20:30

Key Insights

主要見解

  • Significant insider control over BMC Medical implies vested interests in company growth
  • A total of 6 investors have a majority stake in the company with 55% ownership
  • Institutions own 13% of BMC Medical
  • BMC Medical的重要內部控制意味着對公司增長有利益關係。
  • 共有6個投資者持有公司的大部分股份,佔總股本的55%。
  • 機構持有BMC Medical的13%。

A look at the shareholders of BMC Medical Co., Ltd. (SZSE:301367) can tell us which group is most powerful. With 32% stake, individual insiders possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

看一下BMC Medical Co.,Ltd.(SZSE:301367)的股東,就可以知道哪個群體最有權力。個人內部持有最多的股份,佔公司的32%。換句話說,該群體在對公司的投資中可以獲得最多的利潤(或最大的損失)。

And following last week's 7.6% decline in share price, insiders suffered the most losses.

上週股價下跌了7.6%,內部持有者遭受了最大的損失。

In the chart below, we zoom in on the different ownership groups of BMC Medical.

下圖展示了BMC Medical不同所有權群體的情況。

ownership-breakdown
SZSE:301367 Ownership Breakdown July 4th 2024
SZSE:301367所有權拆分2024年7月4日

What Does The Institutional Ownership Tell Us About BMC Medical?

機構持股告訴我們BMC Medical是好公司。

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

許多機構衡量其業績的標準是一個近似於當地市場的指數。因此,他們通常更加關注包括在主要指數中的公司。

BMC Medical already has institutions on the share registry. Indeed, they own a respectable stake in the company. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at BMC Medical's earnings history below. Of course, the future is what really matters.

BMC Medical已經有機構持股,他們在公司擁有一定的股權。這意味着那些機構的分析師已經研究過該股票並且看好它。但是和其他人一樣,他們也可能是錯的。如果多個機構同時改變他們對股票的看法,你會看到股價迅速下跌。因此,值得查看BMC Medical下面的收益歷史。當然,未來才是真正重要的。

earnings-and-revenue-growth
SZSE:301367 Earnings and Revenue Growth July 4th 2024
SZSE:301367收入及收益增長情況2024年7月4日

We note that hedge funds don't have a meaningful investment in BMC Medical. With a 13% stake, CEO Zhi Zhuang is the largest shareholder. In comparison, the second and third largest shareholders hold about 12% and 9.2% of the stock. Interestingly, the third-largest shareholder, Bei Chen is also a Member of the Board of Directors, again, indicating strong insider ownership amongst the company's top shareholders.

我們注意到對BMC Medical沒有意義的是對沖基金沒有多少投資。佔13%股份的CEO莊志是最大的股東。其次和第三大股東持有的股票比例分別爲約12%和9.2%。有趣的是,第三大股東陳北也是董事會成員,再次表明公司的大股東中有強烈的內部持股情況。

We also observed that the top 6 shareholders account for more than half of the share register, with a few smaller shareholders to balance the interests of the larger ones to a certain extent.

我們還觀察到,前6大股東持有超過一半的股份登記簿,有一些較小的股東來平衡較大股東的利益。

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There is a little analyst coverage of the stock, but not much. So there is room for it to gain more coverage.

研究機構所有權是衡量和篩選股票預期表現的好方法。研究分析師的看法也可以達到同樣的效果。股票的分析師覆蓋率很低,但不多。因此,可以有更多的空間來增加其覆蓋範圍。

Insider Ownership Of BMC Medical

BMC Medical內部持股情況

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

公司內部人員的定義可能是主觀的,並且在不同的司法管轄區之間是不同的。我們的數據反映了個別內部人員,至少捕捉到了董事會成員。公司管理業務,但首席執行官即使是董事會成員也必須向董事會負責。

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

大多數人認爲內部所有權是積極的,因爲它可以表示董事會與其他股東的利益相一致。但是,在某些場合下,這個團體的權力過於集中。

It seems insiders own a significant proportion of BMC Medical Co., Ltd.. Insiders have a CN¥1.7b stake in this CN¥5.4b business. We would say this shows alignment with shareholders, but it is worth noting that the company is still quite small; some insiders may have founded the business. You can click here to see if those insiders have been buying or selling.

似乎內部持有者擁有BMC Medical Co.Ltd.的相當大的比例。內部持股者持有這家54億元公司的17億元股份。我們認爲這顯示了與股東的利益一致,但值得注意的是,該公司仍然非常小;一些內部持股者可能創立了該業務。您可以單擊此處查看這些內部持有者是否一直在買賣。

General Public Ownership

一般大衆所有權

With a 23% ownership, the general public, mostly comprising of individual investors, have some degree of sway over BMC Medical. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

個人投資者持有BMC Medical即佔23%。儘管這種比例的股權不足以影響決策,但他們仍然可以對公司政策產生集體影響。

Private Equity Ownership

股權投資公司持有8.8%的股份,有能力參與塑造以價值創造爲重點的公司策略。一些投資者可能會因此而受到鼓舞,因爲股權投資公司有時可以鼓勵市場看到公司的價值,從而採取有益的策略。另外,那些持有者可能在將其上市後退出投資。

With an ownership of 6.0%, private equity firms are in a position to play a role in shaping corporate strategy with a focus on value creation. Some investors might be encouraged by this, since private equity are sometimes able to encourage strategies that help the market see the value in the company. Alternatively, those holders might be exiting the investment after taking it public.

持有6.0%股份的私人股本公司在塑造公司價值創造方面起着重要作用。一些投資者可能會因此感到鼓舞,因爲私人股本有時能夠鼓勵市場看到公司的價值。或者,這些持有人可能在公司上市後退出投資。

Private Company Ownership

私有公司的所有權

We can see that Private Companies own 26%, of the shares on issue. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.

我們可以看到私人公司擁有BMC Medical發行的26%股份。這個事實本身很難得出任何結論,因此有必要了解誰擁有這些私人公司。有時,內部人員或其他相關方可能通過單獨的私人公司擁有公共公司的股權。

Next Steps:

下一步:

It's always worth thinking about the different groups who own shares in a company. But to understand BMC Medical better, we need to consider many other factors. For instance, we've identified 2 warning signs for BMC Medical (1 is potentially serious) that you should be aware of.

考慮到不同的持股群體總是值得花時間去思考的,但要更好地了解BMC Medical,我們需要考慮許多其他因素。例如,我們已經發現BMC Medical存在2個警告信號(1個可能是嚴重的),您應該了解。

But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.

但最終,決定該業務所有者將獲得多大利益的是未來而非過去。因此,我們認爲最好查看此免費報告,以了解分析師是否預測更光明的未來。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注:本文中的數據是使用最後一個財務報表日期結束的爲期12個月的數據計算的。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者,發送電子郵件至editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者發送電子郵件至editorial-team@simplywallst.com。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論